StockData
BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31

BIOTRICITY INC.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.05+0.00 (+8.70%)

Close on Oct 19, 2026

Market cap
$1.15M
P/E (TTM)
–
Dividend yield
–

About Biotricity

Surgical & Medical Instruments & Apparatus, SIC 3841

Biotricity Inc. is a medical technology company that provides biometric data monitoring and remote patient monitoring solutions focused on diagnostic and chronic care management. The company primarily targets the ambulatory cardiac outpatient monitoring market, developing products for both clinical and consumer use. Its clinical technologies include the Bioflux mobile cardiac outpatient monitoring system and the Biocore three-lead cardiac monitoring device line, featuring the cellular Biocore Pro patch for electrocardiogram and arrhythmia detection. For consumers, Biotricity offers the Bioheart continuous heart monitor, alongside chronic disease platforms such as Biokit and Biocare. The company sells its diagnostic devices and recurring utilization-based monitoring services to clinics, physicians' offices, hospitals, and independent diagnostic testing facilities.

The company operates across thirty-five states in the United States, utilizing an insourcing business model to supply medical facilities. Biotricity is incorporated in the state of Nevada. It maintains its principal executive offices in Redwood City, California, and also lists headquarters in Nevada and Toronto, Ontario, Canada.

Summary of the business section of Biotricity's latest annual report, written by StockData.

Company profile

Company

Legal name
BIOTRICITY INC.
Headquarters
Redwood City, CA
Address
203 Redwood Parkway, Suite 600 94065
Phone
(800) 590-4155
Employees
46, Mar 31, 2026
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Nevada
Fiscal year ends
March 31
Auditor
SRCO Professional Corporation, Richmond Hill, Ontario, Canada

Stock & identifiers

Ticker
BTCY
Exchange
OTC
IPO date
Feb 19, 2016
Shares outstanding
20M, Aug 19, 2026
Public float
$13.50M, Sep 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-6 reverse, Nov 14, 2023; 1-for-6 reverse, Jul 3, 2023
SEC CIK
1630113
CUSIP
09074H203
ISIN
US09074H2031
LEI
5493000L48S51ZYDK260
EIN
47-2548273

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Biotricity's leadership is listed in its proxy statement, last filed Aug 5, 2024.

Employees

Headcount reported in annual reports

“We currently have 46 full-time employees and approximately 20 consultants who are based in our offices located in Silicon Valley, California and Toronto, Canada.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 17, 2026Late filingNotification of late filing
Jun 29, 2026Late filingNotification of late filing
Jul 1, 2025Late filingNotification of late filing
Feb 14, 2025Late filingNotification of late filing
Oct 15, 2024DelistingNotice of delisting from exchange (Form 25)
Aug 15, 2024Late filingNotification of late filing
Aug 7, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 1, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 3, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Apr 23, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Feb 14, 2024Late filingNotification of late filing
Feb 2, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 4, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jan 20, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jun 29, 2022Late filingNotification of late filing
Aug 25, 2021ListingRegistration of securities on an exchange (Form 8-A)
Aug 17, 2021Late filingNotification of late filing
Aug 15, 2019Late filingNotification of late filing
Jul 1, 2019Late filingNotification of late filing
Feb 13, 2019Late filingNotification of late filing
Jun 29, 2018Late filingNotification of late filing
Nov 14, 2016Late filingNotification of late filing
Apr 13, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 31, 2016Late filingNotification of late filing
Feb 3, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 3, 2016Auditor changeChange in certifying accountant (8-K Item 4.01)
Jan 5, 2016Name changeName changed from METASOLUTIONS, INC. to BIOTRICITY INC.